Single-agent Pamidronate for Palliative Therapy of Canine Appendicular Osteosarcoma Bone Pain

Abstract

Substantiated by reductions in CPIS and increases in rBMD, single-agent pamidronate administered intravenously with NSAID therapy relieves pain and diminishes pathologic bone turnover associated with appendicular OSA in a subset of dogs.